Quarterly EPS Estimate For Aduro BioTech Inc (NASDAQ:ADRO) Cited At $-0.51


The average EPS estimate for Aduro BioTech Inc (NASDAQ:ADRO) for the three months ending 2016-12-31 is given as $-0.51.

You find that 7 days ago, the average EPS estimate on the stock was $-0.51, while for the 30 days ago the average EPS estimate stood at $-0.51.

If you look back further, you see that the average EPS estimate for Aduro BioTech Inc (NASDAQ:ADRO) 60 days ago was given as -0.51, while EPS estimate 90 days ago was quoted at $-0.51.

The change in the stock’s EPS estimate over the last 7 days works out to 0%.

EPS estimate revisions

Over the last 7 days, EPS estimates for Aduro BioTech Inc (NASDAQ:ADRO) have been revised up 0 times. In the same period, the EPS estimate has been revised down 0 times.

In the last 30 days, the stock has had its EPS estimate revised up 1 and it has been revised up 1 times over the last 60 days.

Up revisions in the last 90 days are 1 and up revisions in the last 120 days are 1.

But for the last 18 days, the company has seen its EPS revised up 0 times, offset by 1 down revisions in the same period.

The down revisions of EPS in last 30, 60, 90 and 120 days were 2, 2, 2 and 2.

What About EPS Surprises

Analysts predicted EPS of $-0.51 for Aduro BioTech Inc (NASDAQ:ADRO) for the period ended 2. But the company ended up posting actual EPS of $0.03 on 2016-08-03. The EPS estimate cited was worked out based on 4 estimates that analysts had issued on the stock.

Therefore, Aduro BioTech Inc (NASDAQ:ADRO) posted EPS surprise of $0.08 per share in dollar terms, which works out to 160%. The standard deviation of the actual EPS reported by the company and the average EPS estimate immediately before the earnings were released works out to $0.23.

Quarterly Sales Estimates

For the fiscal year 2016, the mean and median annual sales estimates for the company are given as $4.231 and $3.952. The estimates are based on the projections of 4 analysts.

So far, the highest annual sales estimate for Aduro BioTech Inc (NASDAQ:ADRO) stands at$5.32. That compares with the lowest annual sales estimate of $3.7. Calculating the standard deviation of the extreme annual sales estimates leads you to 0.763%.

Annual sales estimate adjustments

In the last 7 days, 4 analysts have raised their annual sales estimates for the company. But over the same period, 4 analysts have trimmed their annual sales estimates.

With that, you find that the percentage change in mean annual sales estimate in the last 7 days works out to 0%.

Over the last one month, though, 4 analysts moved to raise their sales estimates for Aduro BioTech Inc (NASDAQ:ADRO). That compares with 4 analysts who cut their sales estimate for the company in the same period. That leads you to -5.515% as the mean sales estimate change over the last one month.

If you look back further, you see that over the last three months, 4 analysts have moved raise their sales estimates Aduro BioTech Inc (NASDAQ:ADRO). That offset by 4 analysts who in the same period lowered their sales estimates for the stock. That works out to percentage change in mean sales estimate of -37.113% over a period of three months.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 2 times, 1 visits today)